Philip A. Starr

Active 1996–2025

143
Papers
19,221
Citations
75
h-index
131
i10-index

Citations

Citations per year for Philip A. Starr1979: 2 citations1984: 2 citations1993: 1 citations1995: 3 citations1996: 1 citations1997: 3 citations1998: 8 citations1999: 17 citations2000: 17 citations2001: 31 citations2002: 42 citations2003: 34 citations2004: 62 citations2005: 64 citations2006: 61 citations2007: 59 citations2008: 95 citations2009: 103 citations2010: 103 citations2011: 135 citations2012: 117 citations2013: 148 citations2014: 164 citations2015: 169 citations2016: 157 citations2017: 151 citations2018: 207 citations2019: 564 citations2020: 631 citations2021: 666 citations2022: 652 citations2023: 574 citations2024: 806 citations2025: 546 citations2026: 35 citations1980–1983: no citations, so these years are not shown1985–1992: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,961 citing papers, 31.5% of this breakdownUnited Kingdom: 552 citing papers, 8.9% of this breakdownGermany: 533 citing papers, 8.5% of this breakdownChina: 434 citing papers, 7% of this breakdownCanada: 328 citing papers, 5.3% of this breakdownFrance: 263 citing papers, 4.2% of this breakdownItaly: 244 citing papers, 3.9% of this breakdownNetherlands: 187 citing papers, 3% of this breakdownSpain: 146 citing papers, 2.3% of this breakdownSwitzerland: 140 citing papers, 2.2% of this breakdownAustralia: 131 citing papers, 2.1% of this breakdownJapan: 122 citing papers, 2% of this breakdown
0%31.5%Other 19.1%

Fields

  • Medicine62.3%
  • Neuroscience25.1%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Engineering3.1%
  • Psychology1.3%
  • Computer Science1%
  • Other1.4%

Topics

  • Neurological disorders and treatments20.2%
  • Parkinson's Disease Mechanisms and Treatments11.9%
  • Neuroscience and Neural Engineering7.7%
  • Transcranial Magnetic Stimulation Studies5.5%
  • EEG and Brain-Computer Interfaces4.9%
  • Neural dynamics and brain function4%
  • Other45.8%

Coauthors

All papers

Open in search
  1. Closed-loop neuromodulation in an individual with treatment-resistant depression

    Authors: , , , , , , , , , , , , - Nature Medicine 2021 cited by 514

  2. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2021 cited by 356

  3. Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson’s disease: a blinded randomized feasibility trial

    Authors: , , , , , , , , , - Nature Medicine 2024 cited by 203

  4. Beta Oscillations in Working Memory, Executive Control of Movement and Thought, and Sensorimotor Function

    Authors: , , , , , - Journal of Neuroscience 2019 cited by 348

  5. Adaptive deep brain stimulation for Parkinson’s disease using motor cortex sensing

    Authors: , , , , , , , , - Journal of Neural Engineering 2018 cited by 412

  6. Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 1,342

  7. Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease

    Authors: , , , , , , , , , - Journal of Neuroscience 2016 cited by 336

  8. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease

    Authors: , , , , , , - Nature Neuroscience 2015 cited by 646

  9. Exaggerated phase–amplitude coupling in the primary motor cortex in Parkinson disease

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 571

  10. A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease

    Authors: , , , , , , , , , , , , , - Sensors 2021 cited by 85

  11. Prefrontal-Subthalamic Hyperdirect Pathway Modulates Movement Inhibition in Humans

    Authors: , , , , , , , - Neuron 2020 cited by 257

  12. First-in-human prediction of chronic pain state using intracranial neural biomarkers

    Authors: , , , , , , , , , , - Nature Neuroscience 2023 cited by 137

  13. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Borgognon, François Bourre, Michel Goillandeau, Wai Kin D. Ko, Laurent Petit, Qin Li, Rik Buschman, Nicholas Buse, Maria S. Yaroshinsky, Jean‐Baptiste Ledoux, Fabio Becce, Mayté Castro Jiménez, Julien F. Bally, Timothy Denison, Dominique Guehl, Auke Jan Ijspeert, Marco Capogrosso, Jordan W. Squair, Léonie Asboth, Philip A. Starr, Doris D. Wang, Stéphanie P. Lacour, Silvestro Micera, Chuan Qin, Jocelyne Bloch, Erwan Bézard, Grégoire Courtine - Nature Medicine 2023 cited by 85

  14. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

    Authors: , , , , , , , , , - Neurology 2009 cited by 431

  15. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2010 cited by 680

  16. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrin M. Buetefisch, Robert E. Gross, Corneliu Luca, Jonathan Jagid, Gonzalo J. Revuelta, István Takács, Michael Pourfar, Alon Y. Mogilner, Andrew P. Duker, George Mandybur, Joshua M. Rosenow, Scott E. Cooper, Michael C. Park, Suketu M. Khandhar, Mark Sedrak, Fenna T. Phibbs, Julie G. Pilitsis, Ryan J. Uitti, Philip A. Starr - The Lancet Neurology 2020 cited by 151

  17. Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's Disease

    Authors: , , , , , - Journal of Neuroscience 2017 cited by 239

  18. Elevated synchrony in Parkinson disease detected with electroencephalography

    Authors: , , , , , - Annals of Neurology 2015 cited by 169

  19. Cortical Potentials Evoked by Subthalamic Stimulation Demonstrate a Short Latency Hyperdirect Pathway in Humans

    Authors: , , , , , , - Journal of Neuroscience 2018 cited by 170

  20. Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease

    Authors: , , , , , , , , , - Human Gene Therapy 2012 cited by 299

  21. Motor network gamma oscillations in chronic home recordings predict dyskinesia in Parkinson’s disease

    Authors: , , , , , , , , , - Brain 2024 cited by 51

  22. Personalized chronic adaptive deep brain stimulation outperforms conventional stimulation in Parkinson’s disease

    Authors: , , , , , , , , , - medRxiv 2023 cited by 50

  23. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

    Authors: , , , , , , , , , , - The Lancet Neurology 2008 cited by 587

  24. The Neurophysiology of Sleep in Parkinson's Disease

    Authors: , , , , , - Movement Disorders 2021 cited by 75